|
2019
|
Invention
|
Methods and monitoring of treatment with vegf/dll4 binding agent. The present invention relates t... |
|
2018
|
Invention
|
Vegf/dll4 binding agents and uses thereof.
The present invention relates to VEGF-binding agents,... |
|
|
Invention
|
Compositions and methods for diagnosing and treating cancer.
An isolated antibody that specifica... |
|
|
Invention
|
Cd40-binding agents and uses thereof. Polypeptides and agents that bind human CD40 are disclosed.... |
|
|
Invention
|
Methods and monitoring of treatment with a wnt pathway inhibitor.
Methods for treating diseases ... |
|
|
Invention
|
Methods for treatment of cancer comprising gitr-binding agents. Methods using novel agents that s... |
|
|
Invention
|
Method for making heteromultimeric molecules.
Methods for making heteromultimeric molecules, suc... |
|
2017
|
Invention
|
Lymphotoxin-beta receptor-binding agents, targeting antibodies, and uses thereof.
Polypeptides, ... |
|
|
Invention
|
Lymphotoxin-beta receptor-binding agents, targeting antibodies, and uses thereof. Polypeptides, a... |
|
|
Invention
|
Methods for treatment of cancer comprising tigit-binding agents. Methods for enhancing the immune... |
|
|
Invention
|
Immunotherapy with binding agents.
Binding agents that modulate the immune response are disclose... |
|
|
Invention
|
Methods and monitoring of treatment with an rspo antagonist. Methods for treating diseases such a... |
|
|
Invention
|
Pvrig-binding agents and uses thereof. Agents that specifically bind PVRIG are disclosed. The PVR... |
|
|
Invention
|
Compositions and methods for diagnosing and treating cancer.
The present invention relates to co... |
|
|
Invention
|
Binding agents that modulate the hippo pathway and uses thereof.
The present invention relates t... |
|
|
Invention
|
Method of treating cancer by administering tumor necrosis factor receptor ligand superfamily (tnf... |
|
|
Invention
|
Compositions and methods for treating and diagnosing cancer.
The present invention relates to co... |
|
|
Invention
|
Rspo binding agents and uses thereof.
The present invention relates to RSPO-binding agents and m... |
|
|
Invention
|
Redirecting immune responses.
Agents that specifically bind tumor-associated antigens (TAA) and ... |
|
|
Invention
|
Redirecting immune responses. Agents that specifically bind tumor-associated antigens (TAA) and c... |
|
|
Invention
|
Rspo3 binding agents and uses thereof.
The present invention relates to RSPO-binding agents, par... |
|
|
Invention
|
Methods and monitoring of treatment with a dll4 antagonist.
Methods for treating diseases such a... |
|
|
Invention
|
Wnt antagonists and methods of treatment and screening.
The present invention relates to composi... |
|
2016
|
Invention
|
Frizzled-binding agents and uses thereof.
Novel anti-cancer agents, including, but not limited t... |
|
|
Invention
|
Methods for treating cancer using rspo3 antagonists. The present invention provides compositions ... |
|
|
Invention
|
Pd-l1-binding agents and uses thereof.
Agents that specifically bind PD-L1 are disclosed. The PD... |
|
|
Invention
|
Pd-l1-binding agents and uses thereof. Agents that specifically bind PD-L1 are disclosed. The PD-... |
|
|
Invention
|
Notch binding agents and antagonists and methods of use thereof.
The present invention relates t... |
|
|
Invention
|
Notch1 receptor binding agents and methods of use thereof.
The present invention relates to comp... |
|
|
Invention
|
Methods and compositions for treatment of cancer. The present invention relates to VEGF-binding a... |
|
|
Invention
|
Combination therapy for treatment of disease.
The present invention provides methods comprising ... |
|
|
Invention
|
Combination therapy for treatment of disease. The present invention provides methods comprising c... |
|
|
Invention
|
Identification of predictive biomarkers associated with wnt pathway inhibitors.
The present inve... |
|
|
Invention
|
Identification of predictive biomarkers associated with wnt pathway inhibitors. The present inven... |
|
|
Invention
|
Methods for identifying and isolating cells expressing a polypeptide. The invention relates to no... |
|
|
Invention
|
Immunotherapy with binding agents. Binding agents that modulate the immune response are disclosed... |
|
2015
|
Invention
|
Combination therapy for treatment of cancer.
Described herein are combination therapies for the ... |
|
|
Invention
|
Combination therapy for treatment of cancer.
The present invention provides methods comprising c... |
|
|
Invention
|
Rspo1 binding agents and uses thereof.
The present invention relates to RSPO-binding agents, par... |
|
|
Invention
|
Treatment of gastric cancer.
The present invention relates to VEGF-binding agents, DLL4-binding ... |
|
|
Invention
|
Notch3 antibodies and uses thereof.
Novel antibodies that specifically bind human NOTCH3 are pro... |
|
|
Invention
|
Methods for treating cancer with notch1 antiboides.
The present invention provides methods for t... |
|
2014
|
Invention
|
Immunotherapy with binding agents.
The present invention provides agents, such as soluble recept... |
